{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:34Z","timestamp":1787032774206,"version":"build-2736575974"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,2]]},"DOI":"10.7759\/cureus.79914","type":"journal-article","created":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:40:11Z","timestamp":1740897611000},"source":"Crossref","is-referenced-by-count":2,"title":["Conventional and Advanced Magnetic Resonance Imaging Biomarkers of Multiple Sclerosis in the Brain"],"prefix":"10.7759","author":[{"given":"Othman I","family":"Alomair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes MP","year":"2021","unstructured":"Wattjes MP, Ciccarelli O, Reich DS, et al.. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol. 2021, 20:653-70. 10.1016\/S1474-4422(21)00095-8","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin FD","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, et al.. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014, 83:278-86. 10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100978","article-title":"Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis","volume":"44","author":"Rocca MA","year":"2024","unstructured":"Rocca MA, Preziosa P, Barkhof F, et al.. Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis. Lancet Reg Health Eur. 2024, 44:100978. 10.1016\/j.lanepe.2024.100978","journal-title":"Lancet Reg Health Eur"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00188","article-title":"Impact of the McDonald Criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis","volume":"10","author":"Schwenkenbecher P","year":"2019","unstructured":"Schwenkenbecher P, Wurster U, Konen FF, et al.. Impact of the McDonald Criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis. Front Neurol. 2019, 10:188. 10.3389\/fneur.2019.00188","journal-title":"Front Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald WI","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, et al.. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50:121-7. 10.1002\/ana.1032","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2007.08.001","article-title":"MRI in multiple sclerosis: what\u2019s inside the toolbox?","volume":"4","author":"Neema M","year":"2007","unstructured":"Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R. MRI in multiple sclerosis: what\u2019s inside the toolbox?. Neurotherapeutics. 2007, 4:602-17. 10.1016\/j.nurt.2007.08.001","journal-title":"Neurotherapeutics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson AJ","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17:162-73. 10.1016\/s1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref8","unstructured":"Multiple Sclerosis Trust. (2025). Accessed. February 17, 2025: https:\/\/mstrust.org.uk\/a-z\/mcdonald-criteria."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.106","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process","volume":"11","author":"Rovira \u00c0","year":"2015","unstructured":"Rovira \u00c0, Wattjes MP, Tintor\u00e9 M, et al.. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol. 2015, 11:471-82. 10.1038\/nrneurol.2015.106","journal-title":"Nat Rev Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.157","article-title":"Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients","volume":"11","author":"Wattjes MP","year":"2015","unstructured":"Wattjes MP, Rovira \u00c0, Miller D, et al.. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients. Nat Rev Neurol. 2015, 11:597-606. 10.1038\/nrneurol.2015.157","journal-title":"Nat Rev Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2003.09.010","article-title":"High-field magnetic resonance techniques for brain research","volume":"13","author":"Kim DS","year":"2003","unstructured":"Kim DS, Garwood M. High-field magnetic resonance techniques for brain research. Curr Opin Neurobiol. 2003, 13:612-9. 10.1016\/j.conb.2003.09.010","journal-title":"Curr Opin Neurobiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jon.13021","article-title":"Improved detection of multiple sclerosis lesions with T2-prepared double inversion recovery at 3T","volume":"32","author":"Costagli M","year":"2022","unstructured":"Costagli M, Lapucci C, Zac\u00e0 D, et al.. Improved detection of multiple sclerosis lesions with T2-prepared double inversion recovery at 3T. J Neuroimaging. 2022, 32:902-9. 10.1111\/jon.13021","journal-title":"J Neuroimaging"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12822","article-title":"Detection of cortical and deep gray matter lesions in multiple sclerosis using DIR and FLAIR at 3T","volume":"31","author":"Park CC","year":"2021","unstructured":"Park CC, Thongkham DW, Sadigh G, et al.. Detection of cortical and deep gray matter lesions in multiple sclerosis using DIR and FLAIR at 3T. J Neuroimaging. 2021, 31:408-14. 10.1111\/jon.12822","journal-title":"J Neuroimaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517751647","article-title":"Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study","volume":"25","author":"Hagens MH","year":"2019","unstructured":"Hagens MH, Burggraaff J, Kilsdonk ID, et al.. Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study. Mult Scler. 2019, 25:352-60. 10.1177\/1352458517751647","journal-title":"Mult Scler"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005825","article-title":"Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study","volume":"91","author":"Hagens MH","year":"2018","unstructured":"Hagens MH, Burggraaff J, Kilsdonk ID, et al.. Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study. Neurology. 2018, 91:e249-57. 10.1212\/WNL.0000000000005825","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmr.2018.01.022","article-title":"Diagnosis of multiple sclerosis through the lens of ultra-high-field MRI","volume":"291","author":"Sati P","year":"2018","unstructured":"Sati P. Diagnosis of multiple sclerosis through the lens of ultra-high-field MRI. J Magn Reson. 2018, 291:101-9. 10.1016\/j.jmr.2018.01.022","journal-title":"J Magn Reson"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6099","article-title":"Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI","volume":"40","author":"Maranzano J","year":"2019","unstructured":"Maranzano J, Dadar M, Rudko DA, et al.. Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI. AJNR Am J Neuroradiol. 2019, 40:1162-9. 10.3174\/ajnr.A6099","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: summary of evidence and recommendations","volume":"16","author":"Gulani V","year":"2017","unstructured":"Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017, 16:564-70. 10.1016\/s1474-4422(17)30158-8","journal-title":"Lancet Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.14","article-title":"The current role of MRI in differentiating multiple sclerosis from its imaging mimics","volume":"14","author":"Geraldes R","year":"2018","unstructured":"Geraldes R, Ciccarelli O, Barkhof F, et al.. The current role of MRI in differentiating multiple sclerosis from its imaging mimics. Nat Rev Neurol. 2018, 14:199-213. 10.1038\/nrneurol.2018.14","journal-title":"Nat Rev Neurol"},{"key":"ref20","article-title":"Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions","volume":"18","author":"van Waesberghe JH","year":"1997","unstructured":"van Waesberghe JH, Castelijns JA, Roser W, et al.. Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions. AJNR Am J Neuroradiol. 1997, 18:1279-85.","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5253","article-title":"Cumulative dose of macrocyclic gadolinium-based contrast agent improves detection of enhancing lesions in patients with multiple sclerosis","volume":"38","author":"Rovira A","year":"2017","unstructured":"Rovira A, Auger C, Huerga E, et al.. Cumulative dose of macrocyclic gadolinium-based contrast agent improves detection of enhancing lesions in patients with multiple sclerosis. AJNR Am J Neuroradiol. 2017, 38:1486-93. 10.3174\/ajnr.A5253","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.38.10.1511","article-title":"Multiple sclerosis: a serial study using MRI in relapsing patients","volume":"38","author":"Isaac C","year":"1988","unstructured":"Isaac C, Li DK, Genton M, et al.. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology. 1988, 38:1511-5. 10.1212\/wnl.38.10.1511","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku LK","year":"2008","unstructured":"Fisniku LK, Brex PA, Altmann DR, et al.. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008, 131:808-17. 10.1093\/brain\/awm329","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10580","article-title":"New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes","volume":"53","author":"Dalton CM","year":"2003","unstructured":"Dalton CM, Brex PA, Miszkiel KA, et al.. New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol. 2003, 53:673-6. 10.1002\/ana.10580","journal-title":"Ann Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-024-01327-7","article-title":"Comparison between the diagnostic utility of three-dimensional fluid attenuated inversion recovery (3D FLAIR) and three dimensional double inversion recovery (3D DIR) magnetic resonance sequences in the assessment of overall load of multiple sclerosis lesions in the brain","volume":"55","author":"Saad NS","year":"2024","unstructured":"Saad NS, Gad AA, Elzoghby MM, Ibrahim HR. Comparison between the diagnostic utility of three-dimensional fluid attenuated inversion recovery (3D FLAIR) and three dimensional double inversion recovery (3D DIR) magnetic resonance sequences in the assessment of overall load of multiple sclerosis lesions in the brain. EJRNM. 2024, 55:156. 10.1186\/s43055-024-01327-7","journal-title":"EJRNM"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48136","article-title":"Determination of efficiency of 3D fluid-attenuated inversion recovery (FLAIR) in the imaging of multiple sclerosis in comparison with 2D FLAIR at 3-Tesla MRI","volume":"15","author":"Kummari S","year":"2023","unstructured":"Kummari S, Burra KG, Reddy VR, Das S, Anilkumar C. Determination of efficiency of 3D fluid-attenuated inversion recovery (FLAIR) in the imaging of multiple sclerosis in comparison with 2D FLAIR at 3-Tesla MRI. Cureus. 2023, 15:e48136. 10.7759\/cureus.48136","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-005-0070-8","article-title":"FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla","volume":"16","author":"Bachmann R","year":"2006","unstructured":"Bachmann R, Reilmann R, Schwindt W, Kugel H, Heindel W, Kr\u00e4mer S. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. Eur Radiol. 2006, 16:915-21. 10.1007\/s00330-005-0070-8","journal-title":"Eur Radiol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103756","article-title":"MS or not MS: T2-weighted imaging (T2WI)-based radiomic findings distinguish MS from its mimics","volume":"61","author":"He T","year":"2022","unstructured":"He T, Zhao W, Mao Y, et al.. MS or not MS: T2-weighted imaging (T2WI)-based radiomic findings distinguish MS from its mimics. Mult Scler Relat Disord. 2022, 61:103756. 10.1016\/j.msard.2022.103756","journal-title":"Mult Scler Relat Disord"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz144","article-title":"Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines","volume":"142","author":"Filippi M","year":"2019","unstructured":"Filippi M, Preziosa P, Banwell BL, et al.. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain. 2019, 142:1858-75. 10.1093\/brain\/awz144","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-019-0028-5","article-title":"T1 inversion recovery pulse sequence: could it replace T1 spin echo sequence in neuroimaging by improving tissue contrast?","volume":"50","author":"Shawky M","year":"2019","unstructured":"Shawky M, Habib R, Elsawaf A. T1 inversion recovery pulse sequence: could it replace T1 spin echo sequence in neuroimaging by improving tissue contrast?. EJRNM. 2019, 50:26. 10.1186\/s43055-019-0028-5","journal-title":"EJRNM"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-022-11488-y","article-title":"Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective","volume":"270","author":"Filippi M","year":"2023","unstructured":"Filippi M, Preziosa P, Arnold DL, et al.. Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective. J Neurol. 2023, 270:1286-99. 10.1007\/s00415-022-11488-y","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241293579","article-title":"Emerging MRI biomarkers for the diagnosis of multiple sclerosis","volume":"30","author":"Maggi P","year":"2024","unstructured":"Maggi P, Absinta M. Emerging MRI biomarkers for the diagnosis of multiple sclerosis. Mult Scler. 2024, 30:1704-13. 10.1177\/13524585241293579","journal-title":"Mult Scler"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2361040450","article-title":"Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging","volume":"236","author":"Geurts JJ","year":"2005","unstructured":"Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005, 236:254-60. 10.1148\/radiol.2361040450","journal-title":"Radiology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2023.04.009","article-title":"Improved detection of juxtacortical lesions using highly accelerated double inversion-recovery MRI in patients with multiple sclerosis","volume":"104","author":"Lespagnol M","year":"2023","unstructured":"Lespagnol M, Massire A, Megdiche I, et al.. Improved detection of juxtacortical lesions using highly accelerated double inversion-recovery MRI in patients with multiple sclerosis. Diagn Interv Imaging. 2023, 104:401-9. 10.1016\/j.diii.2023.04.009","journal-title":"Diagn Interv Imaging"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000001152","article-title":"Imaging cortical lesions in multiple sclerosis","volume":"36","author":"Mainero C","year":"2023","unstructured":"Mainero C, Treaba CA, Barbuti E. Imaging cortical lesions in multiple sclerosis. Curr Opin Neurol. 2023, 36:222-8. 10.1097\/WCO.0000000000001152","journal-title":"Curr Opin Neurol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore M","year":"2015","unstructured":"Tintore M, Rovira \u00c0, R\u00edo J, et al.. Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain. 2015, 138:1863-74. 10.1093\/brain\/awv105","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"Minneboo A","year":"2004","unstructured":"Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol. 2004, 61:217-21. 10.1001\/archneur.61.2.217","journal-title":"Arch Neurol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519864933","article-title":"Infratentorial and spinal cord lesions: cumulative predictors of long-term disability?","volume":"26","author":"Dekker I","year":"2020","unstructured":"Dekker I, Sombekke MH, Balk LJ, et al.. Infratentorial and spinal cord lesions: cumulative predictors of long-term disability?. Mult Scler. 2020, 26:1381-91. 10.1177\/1352458519864933","journal-title":"Mult Scler"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181feb26f","article-title":"Brainstem lesions in clinically isolated syndromes","volume":"75","author":"Tintore M","year":"2010","unstructured":"Tintore M, Rovira A, Arrambide G, et al.. Brainstem lesions in clinically isolated syndromes. Neurology. 2010, 75:1933-8. 10.1212\/WNL.0b013e3181feb26f","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105271","article-title":"Infratentorial lesions as a radiological biomarker for progression independent of relapse activity (PIRA) in patients with multiple sclerosis in Saudi population","volume":"80","author":"Assiri F","year":"2023","unstructured":"Assiri F, Younis H, Alhartani M. Infratentorial lesions as a radiological biomarker for progression independent of relapse activity (PIRA) in patients with multiple sclerosis in Saudi population. Mult Scler Relat Disord . 2023, 80:105271. 10.1016\/j.msard.2023.105271","journal-title":"Mult Scler Relat Disord"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis","volume":"75","author":"Filippi M","year":"2010","unstructured":"Filippi M, Rocca MA, Calabrese M, et al.. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010, 75:1988-94. 10.1212\/WNL.0b013e3181ff96f6","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging","volume":"100","author":"Cortese R","year":"2023","unstructured":"Cortese R, Prados Carrasco F, Tur C, et al.. Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging. Neurology. 2023, 100:e308-23. 10.1212\/WNL.0000000000201465","journal-title":"Neurology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610821104","article-title":"High-field MRI of brain cortical substructure based on signal phase","volume":"104","author":"Duyn JH","year":"2007","unstructured":"Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA. 2007, 104:11796-801. 10.1073\/pnas.0610821104","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303023","article-title":"Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI","volume":"83","author":"Sethi V","year":"2012","unstructured":"Sethi V, Yousry TA, Muhlert N, et al.. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry. 2012, 83:877-82. 10.1136\/jnnp-2012-303023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref45","article-title":"Improving the detection of grey matter lesions in MS using MRI: a comparison of double inversion recovery and phase sensitive inversion recovery (S51.001)","volume":"78","author":"Sethi V","year":"2012","unstructured":"Sethi V, Yousry T, Muhlert N, et al.. Improving the detection of grey matter lesions in MS using MRI: a comparison of double inversion recovery and phase sensitive inversion recovery (S51.001). Neurol. 2012, 78:S51.001.","journal-title":"Neurol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b64bf7","article-title":"In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI","volume":"73","author":"Mainero C","year":"2009","unstructured":"Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, Kinkel RP. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009, 73:941-8. 10.1212\/WNL.0b013e3181b64bf7","journal-title":"Neurology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg182","article-title":"Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years","volume":"126","author":"Bagnato F","year":"2003","unstructured":"Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, Frank JA. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain. 2003, 126:1782-9. 10.1093\/brain\/awg182","journal-title":"Brain"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.22619","article-title":"Brain size, sex, and the aging brain","volume":"36","author":"J\u00e4ncke L","year":"2015","unstructured":"J\u00e4ncke L, M\u00e9rillat S, Liem F, H\u00e4nggi J. Brain size, sex, and the aging brain. Hum Brain Mapp. 2015, 36:150-69. 10.1002\/hbm.22619","journal-title":"Hum Brain Mapp"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options","volume":"10","author":"Andravizou A","year":"2019","unstructured":"Andravizou A, Dardiotis E, Artemiadis A, et al.. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options. Auto Immun Highlights. 2019, 10:7. 10.1186\/s13317-019-0117-5","journal-title":"Auto Immun Highlights"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni G","year":"2016","unstructured":"Giovannoni G, Butzkueven H, Dhib-Jalbut S, et al.. Brain health: time matters in multiple sclerosis. Mult Scler Relat Disord. 2016, 9:S5-S48. 10.1016\/j.msard.2016.07.003","journal-title":"Mult Scler Relat Disord"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2023.102789","article-title":"SynthSeg: segmentation of brain MRI scans of any contrast and resolution without retraining","volume":"86","author":"Billot B","year":"2023","unstructured":"Billot B, Greve DN, Puonti O, et al.. SynthSeg: segmentation of brain MRI scans of any contrast and resolution without retraining. Med Image Anal. 2023, 86:102789. 10.1016\/j.media.2023.102789","journal-title":"Med Image Anal"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103354","article-title":"An open-source tool for longitudinal whole-brain and white matter lesion segmentation","volume":"38","author":"Cerri S","year":"2023","unstructured":"Cerri S, Greve DN, Hoopes A, Lundell H, Siebner HR, M\u00fchlau M, Van Leemput K. An open-source tool for longitudinal whole-brain and white matter lesion segmentation. Neuroimage Clin. 2023, 38:103354. 10.1016\/j.nicl.2023.103354","journal-title":"Neuroimage Clin"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.581537","article-title":"Gray matter matters: a longitudinal magnetic resonance voxel-based morphometry study of primary progressive multiple sclerosis","volume":"11","author":"Rothstein TL","year":"2020","unstructured":"Rothstein TL. Gray matter matters: a longitudinal magnetic resonance voxel-based morphometry study of primary progressive multiple sclerosis. Front Neurol. 2020, 11:581537. 10.3389\/fneur.2020.581537","journal-title":"Front Neurol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2002.1132","article-title":"Improved optimization for the robust and accurate linear registration and motion correction of brain images","volume":"17","author":"Jenkinson M","year":"2002","unstructured":"Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage. 2002, 17:825-41. 10.1006\/nimg.2002.1132","journal-title":"NeuroImage"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson M","year":"2001","unstructured":"Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001, 5:143-56. 10.1016\/S1361-8415(01)00036-6","journal-title":"Med Image Anal"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5876","article-title":"Brain atrophy is associated with disability progression in patients with MS followed in a clinical routine","volume":"39","author":"Ghione E","year":"2018","unstructured":"Ghione E, Bergsland N, Dwyer MG, et al.. Brain atrophy is associated with disability progression in patients with MS followed in a clinical routine. AJNR Am J Neuroradiol. 2018, 39:2237-42. 10.3174\/ajnr.A5876","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019190306","article-title":"Atrophied brain T2 lesion volume at MRI is associated with disability progression and conversion to secondary progressive multiple sclerosis","volume":"293","author":"Genovese AV","year":"2019","unstructured":"Genovese AV, Hagemeier J, Bergsland N, et al.. Atrophied brain T2 lesion volume at MRI is associated with disability progression and conversion to secondary progressive multiple sclerosis. Radiology. 2019, 293:424-33. 10.1148\/radiol.2019190306","journal-title":"Radiology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13904","article-title":"Predicting clinical progression in multiple sclerosis after 6 and 12\u00a0years","volume":"26","author":"Dekker I","year":"2019","unstructured":"Dekker I, Eijlers AJ, Popescu V, et al.. Predicting clinical progression in multiple sclerosis after 6 and 12\u00a0years. Eur J Neurol. 2019, 26:893-902. 10.1111\/ene.13904","journal-title":"Eur J Neurol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516656808","article-title":"Grey matter atrophy is associated with disability increase in natalizumab-treated patients","volume":"23","author":"Ciampi E","year":"2017","unstructured":"Ciampi E, Pareto D, Sastre-Garriga J, et al.. Grey matter atrophy is associated with disability increase in natalizumab-treated patients. Mult Scler. 2017, 23:556-66. 10.1177\/1352458516656808","journal-title":"Mult Scler"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304094","article-title":"Brain atrophy and lesion load predict long term disability in multiple sclerosis","volume":"84","author":"Popescu V","year":"2013","unstructured":"Popescu V, Agosta F, Hulst HE, et al.. Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2013, 84:1082-91. 10.1136\/jnnp-2012-304094","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/jon.12527","article-title":"Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis","volume":"28","author":"Dwyer MG","year":"2018","unstructured":"Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R. Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis. J Neuroimaging. 2018, 28:490-5. 10.1111\/jon.12527","journal-title":"J Neuroimaging"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.199968","article-title":"Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis","volume":"81","author":"Lukas C","year":"2010","unstructured":"Lukas C, Minneboo A, de Groot V, et al.. Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010, 81:1351-6. 10.1136\/jnnp.2009.199968","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2442","article-title":"Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting","volume":"4","author":"von Gumberz J","year":"2016","unstructured":"von Gumberz J, Mahmoudi M, Young K, et al.. Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting. PeerJ. 2016, 4:e2442. 10.7717\/peerj.2442","journal-title":"PeerJ"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104714","article-title":"The association between brain volume loss and disability in multiple sclerosis: a systematic review","volume":"74","author":"Matthews PM","year":"2023","unstructured":"Matthews PM, Gupta D, Mittal D, et al.. The association between brain volume loss and disability in multiple sclerosis: a systematic review. Mult Scler Relat Disord. 2023, 74:104714. 10.1016\/j.msard.2023.104714","journal-title":"Mult Scler Relat Disord"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09740-4","article-title":"Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis","volume":"267","author":"Magon S","year":"2020","unstructured":"Magon S, Tsagkas C, Gaetano L, et al.. Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis. J Neurol. 2020, 267:1536-46. 10.1007\/s00415-020-09740-4","journal-title":"J Neurol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515614091","article-title":"Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: a two-year longitudinal study","volume":"22","author":"Uddin MN","year":"2016","unstructured":"Uddin MN, Lebel RM, Seres P, Blevins G, Wilman AH. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: a two-year longitudinal study. Mult Scler. 2016, 22:1133-43. 10.1177\/1352458515614091","journal-title":"Mult Scler"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306906","article-title":"Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study","volume":"85","author":"Jacobsen C","year":"2014","unstructured":"Jacobsen C, Hagemeier J, Myhr KM, et al.. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. J Neurol Neurosurg Psychiatry. 2014, 85:1109-15. 10.1136\/jnnp-2013-306906","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000681","article-title":"Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS","volume":"7","author":"Muthuraman M","year":"2020","unstructured":"Muthuraman M, Fleischer V, Kroth J, et al.. Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS. Neurol Neuroimmunol Neuroinflamm. 2020, 7:e681. 10.1212\/NXI.0000000000000681","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000132","article-title":"Predictive value of early brain atrophy on response in patients treated with interferon \u03b2","volume":"2","author":"P\u00e9rez-Miralles FC","year":"2015","unstructured":"P\u00e9rez-Miralles FC, Sastre-Garriga J, Vidal-Jordana A, et al.. Predictive value of early brain atrophy on response in patients treated with interferon \u03b2. Neurol Neuroimmunol Neuroinflamm. 2015, 2:e132. 10.1212\/NXI.0000000000000132","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011494","article-title":"Association of gray matter atrophy patterns with clinical phenotype and progression in multiple sclerosis","volume":"96","author":"Rocca MA","year":"2021","unstructured":"Rocca MA, Valsasina P, Meani A, et al.. Association of gray matter atrophy patterns with clinical phenotype and progression in multiple sclerosis. Neurology. 2021, 96:e1561-73. 10.1212\/WNL.0000000000011494","journal-title":"Neurology"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.161.3.3786722","article-title":"Multiple sclerosis: gadolinium enhancement in MR imaging","volume":"161","author":"Grossman RI","year":"1986","unstructured":"Grossman RI, Gonzalez-Scarano F, Atlas SW, Galetta S, Silberberg DH. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology. 1986, 161:721-5. 10.1148\/radiology.161.3.3786722","journal-title":"Radiology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000001054","article-title":"Comprehensive analysis of the spatial distribution of gadolinium, iron, manganese, and phosphorus in the brain of healthy rats after high-dose administrations of gadodiamide and gadobutrol","volume":"59","author":"Hummel L","year":"2024","unstructured":"Hummel L, Frenzel T, Boyken J, Pietsch H, Seeliger E. Comprehensive analysis of the spatial distribution of gadolinium, iron, manganese, and phosphorus in the brain of healthy rats after high-dose administrations of gadodiamide and gadobutrol. Invest Radiol. 2024, 59:150-64. 10.1097\/RLI.0000000000001054","journal-title":"Invest Radiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017161595","article-title":"Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial qbnormalities","volume":"285","author":"McDonald RJ","year":"2017","unstructured":"McDonald RJ, McDonald JS, Kallmes DF, et al.. Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial qbnormalities. Radiology. 2017, 285:546-54. 10.1148\/radiol.2017161595","journal-title":"Radiology"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2014.08.003","article-title":"Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome","volume":"3","author":"Kinkel RP","year":"2014","unstructured":"Kinkel RP, Simon JH, O'Connor P, Hyde R, Pace A. Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome. Mult Scler Relat Disord. 2014, 3:712-9. 10.1016\/j.msard.2014.08.003","journal-title":"Mult Scler Relat Disord"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2009.01221.x","article-title":"Black holes in multiple sclerosis: definition, evolution, and clinical correlations","volume":"122","author":"Sahraian MA","year":"2010","unstructured":"Sahraian MA, Radue EW, Haller S, Kappos L. Black holes in multiple sclerosis: definition, evolution, and clinical correlations. Acta Neurol Scand. 2010, 122:1-8. 10.1111\/j.1600-0404.2009.01221.x","journal-title":"Acta Neurol Scand"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2012.08.004","article-title":"Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis","volume":"1","author":"Tam RC","year":"2012","unstructured":"Tam RC, Traboulsee A, Riddehough A, Li DK. Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis. Neuroimage Clin. 2012, 1:29-36. 10.1016\/j.nicl.2012.08.004","journal-title":"Neuroimage Clin"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.50.5.1282","article-title":"Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis","volume":"50","author":"van Walderveen MA","year":"1998","unstructured":"van Walderveen MA, Kamphorst W, Scheltens P, et al.. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998, 50:1282-8. 10.1212\/wnl.50.5.1282","journal-title":"Neurology"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.47.6.1469","article-title":"Accumulation of hypointense lesions (\"black holes\") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen L","year":"1996","unstructured":"Truyen L, van Waesberghe JH, van Walderveen MA, et al.. Accumulation of hypointense lesions (\"black holes\") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology. 1996, 47:1469-76. 10.1212\/wnl.47.6.1469","journal-title":"Neurology"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507087842","article-title":"Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis","volume":"14","author":"van den Elskamp IJ","year":"2008","unstructured":"van den Elskamp IJ, Lembcke J, Dattola V, et al.. Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. Mult Scler. 2008, 14:764-9. 10.1177\/1352458507087842","journal-title":"Mult Scler"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(00)00259-8","article-title":"Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability","volume":"174","author":"Paolillo A","year":"2000","unstructured":"Paolillo A, Pozzilli C, Gasperini C, et al.. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J Neurol Sci. 2000, 174:85-91. 10.1016\/s0022-510x(00)00259-8","journal-title":"J Neurol Sci"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2001.00147.x","article-title":"T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study","volume":"8","author":"Sailer M","year":"2001","unstructured":"Sailer M, Losseff NA, Wang L, Gawne-Cain ML, Thompson AJ, Miller DH. T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study. Eur J Neurol. 2001, 8:37-42. 10.1046\/j.1468-1331.2001.00147.x","journal-title":"Eur J Neurol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1177\/1051228405283291","article-title":"Clinical-magnetic resonance imaging correlations in multiple sclerosis","volume":"15","author":"Zivadinov R","year":"2005","unstructured":"Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging. 2005, 15:10S-21S. 10.1177\/1051228405283291","journal-title":"J Neuroimaging"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13815","article-title":"Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis","volume":"28","author":"Valizadeh A","year":"2022","unstructured":"Valizadeh A, Fattahi MR, Sadeghi M, Saghab Torbati M, Sahraian MA, Azimi AR. Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis. CNS Neurosci Ther. 2022, 28:648-57. 10.1111\/cns.13815","journal-title":"CNS Neurosci Ther"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2018.0001","article-title":"Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients","volume":"53","author":"Nowaczyk N","year":"2019","unstructured":"Nowaczyk N, Kalinowska-\u0141yszczarz A, Paprzycki W, Michalak S, Ka\u017amierski R, Pawlak MA. Spatial distribution of white matter degenerative lesions and cognitive dysfunction in relapsing-remitting multiple sclerosis patients. Neurol Neurochir Pol. 2019, 53:18-25. 10.5603\/PJNNS.a2018.0001","journal-title":"Neurol Neurochir Pol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/312142","article-title":"GRE T2\u2217-weighted MRI: principles and clinical applications","volume":"2014","author":"Tang MY","year":"2014","unstructured":"Tang MY, Chen TW, Zhang XM, Huang XH. GRE T2\u2217-weighted MRI: principles and clinical applications. Biomed Res Int. 2014, 2014:312142. 10.1155\/2014\/312142","journal-title":"Biomed Res Int"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh253","article-title":"Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI","volume":"127","author":"Werring DJ","year":"2004","unstructured":"Werring DJ, Frazer DW, Coward LJ, et al.. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain. 2004, 127:2265-75. 10.1093\/brain\/awh253","journal-title":"Brain"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s12975-009-0008-6","article-title":"T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral hemorrhage","volume":"1","author":"Wu G","year":"2010","unstructured":"Wu G, Xi G, Hua Y, Sagher O. T2* magnetic resonance imaging sequences reflect brain tissue iron deposition following intracerebral hemorrhage. Transl Stroke Res. 2010, 1:31-4. 10.1007\/s12975-009-0008-6","journal-title":"Transl Stroke Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200253","article-title":"Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis","volume":"11","author":"Borrelli S","year":"2024","unstructured":"Borrelli S, Martire MS, St\u00f6lting A, et al.. Central vein sign, cortical lesions, and paramagnetic rim lesions for the diagnostic and prognostic workup of multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2024, 11:e200253. 10.1212\/NXI.0000000000200253","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241271988","article-title":"Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis","volume":"30","author":"Toljan K","year":"2024","unstructured":"Toljan K, Daboul L, Raza P, et al.. Diagnostic performance of central vein sign versus oligoclonal bands for multiple sclerosis. Mult Scler. 2024, 30:1268-77. 10.1177\/13524585241271988","journal-title":"Mult Scler"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120208","article-title":"FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins","volume":"265","author":"Sati P","year":"2012","unstructured":"Sati P, George IC, Shea CD, Gait\u00e1n MI, Reich DS. FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology. 2012, 265:926-32. 10.1148\/radiol.12120208","journal-title":"Radiology"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120707","article-title":"Quantitative susceptibility mapping in multiple sclerosis","volume":"267","author":"Langkammer C","year":"2013","unstructured":"Langkammer C, Liu T, Khalil M, et al.. Quantitative susceptibility mapping in multiple sclerosis. Radiology. 2013, 267:551-9. 10.1148\/radiol.12120707","journal-title":"Radiology"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.18383\/j.tom.2015.00136","article-title":"Quantitative susceptibility mapping: contrast mechanisms and clinical applications","volume":"1","author":"Liu C","year":"2015","unstructured":"Liu C, Wei H, Gong NJ, Cronin M, Dibb R, Decker K. Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography. 2015, 1:3-17. 10.18383\/j.tom.2015.00136","journal-title":"Tomography"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab029","article-title":"Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis","volume":"144","author":"Granziera C","year":"2021","unstructured":"Granziera C, Wuerfel J, Barkhof F, et al.. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain. 2021, 144:1296-311. 10.1093\/brain\/awab029","journal-title":"Brain"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.24835\/1607-0763-1256","article-title":"Quantitative susceptibility mapping (QSM) in deep gray matter as a neurodegeneration marker in relapsing-remitting and secondary-progressive multiple sclerosis","volume":"27","author":"Matrosova M","year":"2023","unstructured":"Matrosova M, Bryukhov VV, Popova EV, Belskaya GN, Krotenkova MV. Quantitative susceptibility mapping (QSM) in deep gray matter as a neurodegeneration marker in relapsing-remitting and secondary-progressive multiple sclerosis. Med Vis. 2023, 27:12-22. 10.24835\/1607-0763-1256","journal-title":"Med Vis"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.25306","article-title":"Decreasing brain iron in multiple sclerosis: the difference between concentration and content in iron MRI","volume":"42","author":"Schweser F","year":"2021","unstructured":"Schweser F, Hagemeier J, Dwyer MG, Bergsland N, Hametner S, Weinstock-Guttman B, Zivadinov R. Decreasing brain iron in multiple sclerosis: the difference between concentration and content in iron MRI. Hum Brain Mapp. 2021, 42:1463-74. 10.1002\/hbm.25306","journal-title":"Hum Brain Mapp"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70093","article-title":"Quantitative susceptibility mapping values quantification in deep gray matter structures for relapsing-remitting multiple sclerosis: a systematic review and meta-analysis","volume":"14","author":"Mohammadi S","year":"2024","unstructured":"Mohammadi S, Ghaderi S, Fatehi F. Quantitative susceptibility mapping values quantification in deep gray matter structures for relapsing-remitting multiple sclerosis: a systematic review and meta-analysis. Brain Behav. 2024, 14:e70093. 10.1002\/brb3.70093","journal-title":"Brain Behav"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fnimg.2024.1359630","article-title":"Iron load in the normal aging brain measured with QSM and R2* at 7T: findings of the SENIOR cohort","volume":"3","author":"Guevara M","year":"2024","unstructured":"Guevara M, Roche S, Brochard V, et al.. Iron load in the normal aging brain measured with QSM and R2* at 7T: findings of the SENIOR cohort. Front Neuroimaging. 2024, 3:1359630. 10.3389\/fnimg.2024.1359630","journal-title":"Front Neuroimaging"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.166","article-title":"The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative","volume":"12","author":"Sati P","year":"2016","unstructured":"Sati P, Oh J, Constable RT, et al.. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016, 12:714-22. 10.1038\/nrneurol.2016.166","journal-title":"Nat Rev Neurol"},{"key":"ref99","article-title":"Multicenter automated central vein sign detection performs as well as manual assessment for the diagnosis of multiple sclerosis","author":"Manning AR","year":"2024","unstructured":"Manning AR, Letchuman V, Martin ML, et al.. Multicenter automated central vein sign detection performs as well as manual assessment for the diagnosis of multiple sclerosis. AJNR Am J Neuroradiol. 2024,","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.52208","article-title":"Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis","volume":"11","author":"Margoni M","year":"2024","unstructured":"Margoni M, Preziosa P, Pagani E, et al.. Assessment of central vein sign and paramagnetic rim lesions in pediatric multiple sclerosis. Ann Clin Transl Neurol. 2024, 11:3031-6. 10.1002\/acn3.52208","journal-title":"Ann Clin Transl Neurol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8083","article-title":"Central vein sign in multiple sclerosis: a comparison study of the diagnostic performance of 3T versus 7T MRI","volume":"45","author":"Okromelidze L","year":"2023","unstructured":"Okromelidze L, Patel V, Singh RB, et al.. Central vein sign in multiple sclerosis: a comparison study of the diagnostic performance of 3T versus 7T MRI. AJNR Am J Neuroradiol. 2023, 45:76-81. 10.3174\/ajnr.A8083","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.51.3_suppl_3.s47","article-title":"Diffusion-weighted MRI for evaluation of acute stroke","volume":"51","author":"Albers GW","year":"1998","unstructured":"Albers GW. Diffusion-weighted MRI for evaluation of acute stroke. Neurology. 1998, 51:S47-9. 10.1212\/wnl.51.3_suppl_3.s47","journal-title":"Neurology"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13040622","article-title":"The value of various post-processing modalities of diffusion weighted imaging in the detection of multiple sclerosis","volume":"13","author":"Alghamdi AJ","year":"2023","unstructured":"Alghamdi AJ. The value of various post-processing modalities of diffusion weighted imaging in the detection of multiple sclerosis. Brain Sci. 2023, 13:622. 10.3390\/brainsci13040622","journal-title":"Brain Sci"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-021-02819-3","article-title":"Clinical applications of diffusion-weighted sequence in brain imaging: beyond stroke","volume":"64","author":"Gaddamanugu S","year":"2022","unstructured":"Gaddamanugu S, Shafaat O, Sotoudeh H, Sarrami AH, Rezaei A, Saadatpour Z, Singhal A. Clinical applications of diffusion-weighted sequence in brain imaging: beyond stroke. Neuroradiology. 2022, 64:15-30. 10.1007\/s00234-021-02819-3","journal-title":"Neuroradiology"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v8.i9.785","article-title":"Diffusion weighted imaging: technique and applications","volume":"8","author":"Baliyan V","year":"2016","unstructured":"Baliyan V, Das CJ, Sharma R, Gupta AK. Diffusion weighted imaging: technique and applications. World J Radiol. 2016, 8:785-98. 10.4329\/wjr.v8.i9.785","journal-title":"World J Radiol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.243716","article-title":"Detecting white matter alterations in multiple sclerosis using advanced diffusion magnetic resonance imaging","volume":"14","author":"Mustafi SM","year":"2019","unstructured":"Mustafi SM, Harezlak J, Kodiweera C, Randolph JS, Ford JC, Wishart HA, Wu YC. Detecting white matter alterations in multiple sclerosis using advanced diffusion magnetic resonance imaging. Neural Regen Res. 2019, 14:114-23. 10.4103\/1673-5374.243716","journal-title":"Neural Regen Res"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A2975","article-title":"Reduced diffusion in a subset of acute MS lesions: a serial multiparametric MRI study","volume":"33","author":"Eisele P","year":"2012","unstructured":"Eisele P, Szabo K, Griebe M, Rossmanith C, F\u00f6rster A, Hennerici M, Gass A. Reduced diffusion in a subset of acute MS lesions: a serial multiparametric MRI study. AJNR Am J Neuroradiol. 2012, 33:1369-73. 10.3174\/ajnr.A2975","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_420_19","article-title":"Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques","volume":"8","author":"Arashloo FT","year":"2019","unstructured":"Arashloo FT, Hanzaei FF, Sedighi B, Amjad G, Younesi L. Efficacy of diffusion-weighted imaging in symptomatic and asymptomatic multiple sclerotic plaques. J Family Med Prim Care. 2019, 8:2409-13. 10.4103\/jfmpc.jfmpc_420_19","journal-title":"J Family Med Prim Care"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.31661\/jbpe.v0i0.925","article-title":"Detection of active plaques in multiple sclerosis using 3 and 12 directional diffusion-weighted imaging: comparison with gadolinium-enhanced MR imaging","volume":"10","author":"Meftahi GH","year":"2020","unstructured":"Meftahi GH, Jahromi GP, Azari A, Ghaemmaghami P. Detection of active plaques in multiple sclerosis using 3 and 12 directional diffusion-weighted imaging: comparison with gadolinium-enhanced MR imaging . J Biomed Phys Eng. 2020, 10:737-44. 10.31661\/jbpe.v0i0.925","journal-title":"J Biomed Phys Eng"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512445407","article-title":"Acute demyelinating lesions with restricted diffusion in multiple sclerosis","volume":"18","author":"Balashov KE","year":"2012","unstructured":"Balashov KE, Lindzen E. Acute demyelinating lesions with restricted diffusion in multiple sclerosis. Mult Scler. 2012, 18:1745-53. 10.1177\/1352458512445407","journal-title":"Mult Scler"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.12659\/PJR.895325","article-title":"Importance of diffusion weighted magnetic resonance imaging in evaluation of the treatment efficacy in multiple sclerosis patients with acute attacks","volume":"80","author":"Sahin T","year":"2015","unstructured":"Sahin T, Bozgeyik Z, Menzilcioglu MS, Citil S, Erbay MF. Importance of diffusion weighted magnetic resonance imaging in evaluation of the treatment efficacy in multiple sclerosis patients with acute attacks. Pol J Radiol. 2015, 80:544-8. 10.12659\/PJR.895325","journal-title":"Pol J Radiol"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69383-3","article-title":"The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-\u03b2 therapy in the 3-year follow-up: a preliminary report","volume":"10","author":"Zacharzewska-Gondek A","year":"2020","unstructured":"Zacharzewska-Gondek A, Pokryszko-Dragan A, Budrewicz S, S\u0105siadek M, Trybek G, Bladowska J. The role of ADC values within the normal-appearing brain in the prognosis of multiple sclerosis activity during interferon-\u03b2 therapy in the 3-year follow-up: a preliminary report. Sci Rep. 2020, 10:12828. 10.1038\/s41598-020-69383-3","journal-title":"Sci Rep"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2492071681","article-title":"Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study","volume":"249","author":"Sasaki M","year":"2008","unstructured":"Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, Shibata E. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study. Radiology. 2008, 249:624-30. 10.1148\/radiol.2492071681","journal-title":"Radiology"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-398398-5.00004-7","article-title":"Principle of diffusion tensor imaging","author":"Mori S and Tournier J","year":"2014","unstructured":"Mori S and Tournier J. Principle of diffusion tensor imaging. Introduction to Diffusion Tensor Imaging (Second Edition) And Higher Order Models. Elsevier , 2014. 27-32. 10.1016\/B978-0-12-398398-5.00004-7"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(94)80775-1","article-title":"MR diffusion tensor spectroscopy and imaging","volume":"66","author":"Basser PJ","year":"1994","unstructured":"Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994, 66:259-67. 10.1016\/S0006-3495(94)80775-1","journal-title":"Biophys J"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122114","article-title":"Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter","volume":"10","author":"Klistorner A","year":"2015","unstructured":"Klistorner A, Vootakuru N, Wang C, et al.. Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter. PLoS One. 2015, 10:e0122114. 10.1371\/journal.pone.0122114","journal-title":"PLoS One"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2013.00031","article-title":"A hitchhiker's guide to diffusion tensor imaging","volume":"7","author":"Soares JM","year":"2013","unstructured":"Soares JM, Marques P, Alves V, Sousa N. A hitchhiker's guide to diffusion tensor imaging. Front Neurosci. 2013, 7:31. 10.3389\/fnins.2013.00031","journal-title":"Front Neurosci"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.3.304","article-title":"Diffusion tensor magnetic resonance imaging in multiple sclerosis","volume":"56","author":"Filippi M","year":"2001","unstructured":"Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology. 2001, 56:304-11. 10.1212\/wnl.56.3.304","journal-title":"Neurology"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-019-0031-x","article-title":"Diffusion tensor imaging for assessment of normally appearing white matter of the brain and spinal cord in cases of multiple sclerosis: a multi-parametric correlation in view of patient\u2019s clinical status","volume":"50","author":"ElSayed MEKA","year":"2019","unstructured":"ElSayed MEKA, El-Toukhy MMB, Asaad RE, El-Serafy OA. Diffusion tensor imaging for assessment of normally appearing white matter of the brain and spinal cord in cases of multiple sclerosis: a multi-parametric correlation in view of patient\u2019s clinical status. EJRNM. 2019, 50:30. 10.1186\/s43055-019-0031-x","journal-title":"EJRNM"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1177\/19714009211067400","article-title":"Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS","volume":"35","author":"Alshehri A","year":"2022","unstructured":"Alshehri A, Al-Iedani O, Arm J, et al.. Neural diffusion tensor imaging metrics correlate with clinical measures in people with relapsing-remitting MS. Neuroradiol J. 2022, 35:592-9. 10.1177\/19714009211067400","journal-title":"Neuroradiol J"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-023-01155-1","article-title":"Diffusion tensor imaging and voxel-based morphometry in differentiating multiple sclerosis and its mimics","volume":"54","author":"Elkossi SM","year":"2023","unstructured":"Elkossi SM, Sayed SA, Shehata GA, Seif Eldein GS, Ahmed SH, Ali ah. Diffusion tensor imaging and voxel-based morphometry in differentiating multiple sclerosis and its mimics. EJRNM. 2023, 54:216. 10.1186\/s43055-023-01155-1","journal-title":"EJRNM"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194142","article-title":"Diffusivity in the core of chronic multiple sclerosis lesions","volume":"13","author":"Klistorner A","year":"2018","unstructured":"Klistorner A, Wang C, Yiannikas C, et al.. Diffusivity in the core of chronic multiple sclerosis lesions. PLoS One. 2018, 13:e0194142. 10.1371\/journal.pone.0194142","journal-title":"PLoS One"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000184471.83948.e0","article-title":"Diffusion MRI in multiple sclerosis","volume":"65","author":"Rovaris M","year":"2005","unstructured":"Rovaris M, Gass A, Bammer R, Hickman SJ, Ciccarelli O, Miller DH, Filippi M. Diffusion MRI in multiple sclerosis. Neurology. 2005, 65:1526-32. 10.1212\/01.wnl.0000184471.83948.e0","journal-title":"Neurology"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1194","article-title":"Diffusion tensor imaging and disability progression in multiple sclerosis: a 4-year follow-up study","volume":"9","author":"Kolasa M","year":"2019","unstructured":"Kolasa M, Hakulinen U, Brander A, Hagman S, Dastidar P, Elovaara I, Sumelahti ML. Diffusion tensor imaging and disability progression in multiple sclerosis: a 4-year follow-up study. Brain Behav. 2019, 9:e01194. 10.1002\/brb3.1194","journal-title":"Brain Behav"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105494","article-title":"Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis","volume":"84","author":"Wooliscroft L","year":"2024","unstructured":"Wooliscroft L, Salter A, Adusumilli G, et al.. Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis. Mult Scler Relat Disord. 2024, 84:105494. 10.1016\/j.msard.2024.105494","journal-title":"Mult Scler Relat Disord"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-396460-1.00006-8","article-title":"Multiple fibers: beyond the diffusion tensor","author":"Seunarine KK and Alexander DC","year":"2014","unstructured":"Seunarine KK and Alexander DC . Multiple fibers: beyond the diffusion tensor. Diffusion MRI (Second Edition) From Quantitative Measurement to In vivo Neuroanatomy. Heidi Johansen-Berg (ed): Elsevier, 2014. 105-23. 10.1016\/B978-0-12-396460-1.00006-8"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.50903","article-title":"Diffusion basis spectrum imaging for identifying pathologies in MS subtypes","volume":"6","author":"Shirani A","year":"2019","unstructured":"Shirani A, Sun P, Trinkaus K, et al.. Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Ann Clin Transl Neurol. 2019, 6:2323-7. 10.1002\/acn3.50903","journal-title":"Ann Clin Transl Neurol"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102335","article-title":"Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE","volume":"27","author":"La Rosa F","year":"2020","unstructured":"La Rosa F, Abdulkadir A, Fartaria MJ, et al.. Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE. Neuroimage Clin. 2020, 27:102335. 10.1016\/j.nicl.2020.102335","journal-title":"Neuroimage Clin"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-023-01460-3","article-title":"AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis","volume":"14","author":"Schlaeger S","year":"2023","unstructured":"Schlaeger S, Shit S, Eichinger P, et al.. AI-based detection of contrast-enhancing MRI lesions in patients with multiple sclerosis. Insights Imag. 2023, 14:123. 10.1186\/s13244-023-01460-3","journal-title":"Insights Imag"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4283","article-title":"CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis","volume":"33","author":"Maggi P","year":"2020","unstructured":"Maggi P, Fartaria MJ, Jorge J, et al.. CVSnet: A machine learning approach for automated central vein sign assessment in multiple sclerosis. NMR Biomed. 2020, 33:e4283. 10.1002\/nbm.4283","journal-title":"NMR Biomed"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5765","article-title":"Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions","volume":"39","author":"Dworkin JD","year":"2018","unstructured":"Dworkin JD, Sati P, Solomon A, et al.. Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions. AJNR Am J Neuroradiol. 2018, 39:1806-13. 10.3174\/ajnr.A5765","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102412","article-title":"RimNet: a deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis","volume":"28","author":"Barquero G","year":"2020","unstructured":"Barquero G, La Rosa F, Kebiri H, et al.. RimNet: a deep 3D multimodal MRI architecture for paramagnetic rim lesion assessment in multiple sclerosis. Neuroimage Clin. 2020, 28:102412. 10.1016\/j.nicl.2020.102412","journal-title":"Neuroimage Clin"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102796","article-title":"Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging","volume":"32","author":"Lou C","year":"2021","unstructured":"Lou C, Sati P, Absinta M, et al.. Fully automated detection of paramagnetic rims in multiple sclerosis lesions on 3T susceptibility-based MR imaging. Neuroimage Clin. 2021, 32:102796. 10.1016\/j.nicl.2021.102796","journal-title":"Neuroimage Clin"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12100978","article-title":"Changes in MRI workflow of multiple sclerosis after introduction of an AI-software: a qualitative study","volume":"12","author":"Rathmann E","year":"2024","unstructured":"Rathmann E, Hemkemeier P, Raths S, Grothe M, Mankertz F, Hosten N, Flessa S. Changes in MRI workflow of multiple sclerosis after introduction of an AI-software: a qualitative study. Healthcare (Basel). 2024, 12:978. 10.3390\/healthcare12100978","journal-title":"Healthcare (Basel)"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0306999","article-title":"Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors","volume":"19","author":"Campanioni S","year":"2024","unstructured":"Campanioni S, Veiga C, Prieto-Gonz\u00e1lez JM, et al.. Explainable machine learning on baseline MRI predicts multiple sclerosis trajectory descriptors. PLoS One. 2024, 19:e0306999. 10.1371\/journal.pone.0306999","journal-title":"PLoS One"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105611","article-title":"Artificial intelligence in multiple sclerosis management: challenges in a new era","volume":"86","author":"Rodr\u00edguez S","year":"2024","unstructured":"Rodr\u00edguez S. Artificial intelligence in multiple sclerosis management: challenges in a new era. Mult Scler Relat Disord. 2024, 86:105611. 10.1016\/j.msard.2024.105611","journal-title":"Mult Scler Relat Disord"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202405_36289","article-title":"Role of artificial intelligence in multiple sclerosis management","volume":"28","author":"Alshamrani F","year":"2024","unstructured":"Alshamrani F. Role of artificial intelligence in multiple sclerosis management. Eur Rev Med Pharmacol Sci. 2024, 28:3542-7. 10.26355\/eurrev_202405_36289","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338697-conventional-and-advanced-magnetic-resonance-imaging-biomarkers-of-multiple-sclerosis-in-the-brain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:40:16Z","timestamp":1740897616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338697-conventional-and-advanced-magnetic-resonance-imaging-biomarkers-of-multiple-sclerosis-in-the-brain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,2]]},"references-count":137,"URL":"https:\/\/doi.org\/10.7759\/cureus.79914","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,2]]}}}